QHSLab reports 127% YoY ISP revenue growth to $370K in Q1 2026; launches GLP-1 support program

QHSLab, Inc.

2026-Q1 EPS reported $0.00 revenue$728,685

Unaudited Q1 2026 ISP revenue of $370,000, up 127% from $163,000 in Q1 2025.
Launched Q-Connect GLP-1 Support Assessment for anti-obesity medication patients and broader cardiometabolic health.
Growth driven by expanding provider adoption and new product offerings.
Platform expansion into metabolic and behavioral health; CEO cites practical solutions for practices.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.